T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA
Clinical trials for T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA trials appear
Sign up with your email to follow new studies for T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to tame rare blood cancers
Disease control Recruiting nowThis early-phase trial tests two drugs, ruxolitinib and duvelisib, together in people whose T- or NK-cell lymphoma has come back or stopped responding to treatment. The main goal is to find the safest dose of duvelisib when combined with a fixed dose of ruxolitinib. About 70 part…
Matched conditions: T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 23, 2026 23:32 UTC
-
New hope for rare blood cancer: drug trial targets leukemia cells
Disease control Recruiting nowThis study tests a pill called ruxolitinib in 30 adults with a rare type of leukemia (T-LGLL). The drug works by blocking certain enzymes that help cancer cells grow. The main goal is to see if the drug can shrink tumors and improve quality of life, while monitoring side effects.
Matched conditions: T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA
Phase: PHASE2 • Sponsor: Jonathan Brammer • Aim: Disease control
Last updated Jun 17, 2026 12:08 UTC